A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Obesity and cancer form a troubling link in the United States. Over 40% of adults are obese, and more than 70% are overweight.

The 'Ladies First' rapper has partnered with Novo Nordisk to create more awareness around obesity and cardiovascular disease.

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

The number of people prescribed GLP-1 drugs for weight management has skyrocketed over the past five years, according to new ...

Newly released insurance claims data from more than 220,000 people reveal the latest evidence on the role obesity plays in ...

Turkey has launched a nationwide campaign to measure citizens’ weight in public to combat its rising obesity rates — a move ...

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...

Obesity is not caused simply by a sedentary lifestyle and over-eating.” Desk jobs, longer working hours and frequently ...

Obesity also raises the risk of heart disease, which kills 315,000 people every year in the UK - making it the number one cause of death. Carrying dangerous amounts of weight has also been linked ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...